To test the possibility that DNASE1L3 may function as a tumor suppressor, we decided to leverage a previously generated full-body constitutive Dnase1l3-deficient (KO) mouse strain (19) in several models of CRC. The gene discussed is DNASE1L3; the disease is neoplasm.